$1.340
+0.144 (+10.74%)收盤時
BIVI 獲利能力與利潤率
Evaluating the bottom line, BioVie Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -151.06%, provide a clear picture of how effectively BIVI converts its operational activities into shareholder value.
BIVI 同業比較
In the context of the broader market, BIVI competes directly with industry leaders such as TCRX and GUTS. With a market capitalization of $11.63M, it holds a significant position in the sector. When comparing efficiency, BIVI's gross margin of N/A stands against TCRX's 100.00% and GUTS's N/A. Such benchmarking helps identify whether BioVie Inc is trading at a premium or discount relative to its financial performance.
BioVie Inc 財務表現
BioVie has reported negative net income consistently, with the latest quarterly loss at $5,270,299. The current ratio has dropped to 3.59, indicating a decrease in liquidity. The forward P/E ratio is 0, showing no expected earnings growth in the near term.
Financials
相關文章
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。